Paragon Financial Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Hold |
1,795
| – | – | 0.23% | 57 |
|
|
2025
Q1 | $376K | Buy |
1,795
+1
| +0.1% | +$209 | 0.29% | 50 |
|
|
2024
Q4 | $319K | Sell |
1,794
-3,059
| -63% | -$544K | 0.24% | 57 |
|
|
2024
Q3 | $958K | Buy |
4,853
+1
| +0% | +$197 | 0.7% | 28 |
|
|
2024
Q2 | $832K | Hold |
4,852
| – | – | 0.65% | 27 |
|
|
2024
Q1 | $883K | Buy |
4,852
+1
| +0% | +$182 | 0.73% | 25 |
|
|
2023
Q4 | $752K | Sell |
4,851
-256
| -5% | -$39.7K | 0.72% | 23 |
|
|
2023
Q3 | $761K | Hold |
5,107
| – | – | 0.79% | 22 |
|
|
2023
Q2 | $688K | Buy |
5,107
+1
| +0% | +$135 | 0.65% | 26 |
|
|
2023
Q1 | $814K | Buy |
5,106
+8
| +0.2% | +$1.28K | 0.85% | 21 |
|
|
2022
Q4 | $824K | Buy |
5,098
+1,846
| +57% | +$298K | 0.91% | 21 |
|
|
2022
Q3 | $437K | Sell |
3,252
-926
| -22% | -$124K | 0.49% | 35 |
|
|
2022
Q2 | $640K | Buy |
4,178
+50
| +1% | +$7.66K | 0.66% | 26 |
|
|
2022
Q1 | $669K | Hold |
4,128
| – | – | 0.58% | 30 |
|
|
2021
Q4 | $559K | Buy |
+4,128
| New | +$559K | 0.46% | 44 |
|